KALA insider transaction filings
KALA BIO, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-12-22. Screen KALA transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for KALA between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — KALA BIO, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-22 | 4 | Lazar David E. — Chief Executive Officer, Director | Other (J): 368,614 (derivative) | EDGAR |
| 2025-11-26 | 4 | Lazar David E. — Chief Executive Officer, Director | Grant/award (A): 900,000 (derivative) | EDGAR |
| 2025-10-24 | 4 | Kharabi Darius — CHIEF BUSINESS OFFICER | Sale (S): 20,806 @ $0.83 | EDGAR |
| 2025-10-24 | 4 | Reumuth Mary — CHIEF FINANCIAL OFFICER | Sale (S): 32,230 @ $0.83 · Sale (S): 967 @ $0.82 | EDGAR |
| 2025-10-24 | 4 | Bazemore Todd — Director | Sale (S): 47,768 @ $0.83 | EDGAR |
| 2025-10-24 | 4 | Iwicki Mark T — Director | Sale (S): 154,894 @ $0.81 | EDGAR |
| 2025-10-24 | 4 | Brazzell Romulus K — SEE REMARKS | Sale (S): 46,748 @ $0.83 | EDGAR |
| 2025-10-02 | 4 | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN | Sale (S): 21,376 @ $1.60 · Sale (S): 195,425 @ $1.60 · Sale (S): 50,640 @ $1.38 · Sale (S): 462,967 @ $1.38 | EDGAR |
| 2025-09-02 | 4 | Bazemore Todd — SEE REMARKS, Director | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Reumuth Mary — CHIEF FINANCIAL OFFICER | Sale (S): 3,631 @ $4.01 | EDGAR |
| 2025-06-26 | 4 | Kharabi Darius — CHIEF BUSINESS OFFICER | Sale (S): 4,511 @ $4.01 | EDGAR |
| 2025-06-26 | 4 | Bazemore Todd — SEE REMARKS | Sale (S): 4,058 @ $4.01 | EDGAR |
| 2025-06-26 | 4 | Iwicki Mark T — Director | Sale (S): 13,227 @ $4.01 | EDGAR |
| 2025-06-26 | 4 | Brazzell Romulus K — SEE REMARKS | Sale (S): 5,251 @ $4.01 | EDGAR |
| 2025-06-17 | 4 | Farid Marjan — Director | Grant/award (A): 2,450 @ $0 · Grant/award (A): 5,450 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Myers C. Daniel — Director | Grant/award (A): 2,450 @ $0 · Grant/award (A): 5,450 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Iwicki Mark T — Director | Grant/award (A): 2,450 @ $0 · Grant/award (A): 5,450 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Rosen Howard B — Director | Grant/award (A): 2,450 @ $0 · Grant/award (A): 5,450 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | KOVEN ANDREW I — Director | Grant/award (A): 3,050 @ $0 · Grant/award (A): 6,850 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | PERRY GREGORY D — Director | Grant/award (A): 2,450 @ $0 · Grant/award (A): 5,450 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4/A | Iwicki Mark T — Director | Sale (S): 10,866 @ $3.74 | EDGAR |
| 2025-06-04 | 4 | Kharabi Darius — CHIEF BUSINESS OFFICER | Sale (S): 730 @ $3.74 | EDGAR |
| 2025-06-04 | 4 | Reumuth Mary — CHIEF FINANCIAL OFFICER | Sale (S): 2,850 @ $3.74 | EDGAR |
| 2025-06-04 | 4 | Bazemore Todd — SEE REMARKS | Sale (S): 3,390 @ $3.74 | EDGAR |
| 2025-06-04 | 4 | Iwicki Mark T — Director | Sale (S): 10,866 @ $3.74 | EDGAR |
| 2025-06-04 | 4 | Brazzell Romulus K — SEE REMARKS | Sale (S): 3,687 @ $3.74 | EDGAR |
| 2025-03-10 | 4 | Bazemore Todd — SEE REMARKS | Grant/award (A): 45,200 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4/A | Brazzell Romulus K — SEE REMARKS | Holdings only — no transactions reported | EDGAR |
| 2025-01-07 | 4 | Kharabi Darius — CHIEF BUSINESS OFFICER | Grant/award (A): 10,100 @ $0 · Sale (S): 2,021 @ $7.63 · Grant/award (A): 45,200 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Bazemore Todd — SEE REMARKS | Grant/award (A): 10,100 @ $0 · Sale (S): 1,993 @ $7.63 · Grant/award (A): 45,200 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Reumuth Mary — CHIEF FINANCIAL OFFICER | Grant/award (A): 10,100 @ $0 · Sale (S): 1,706 @ $7.63 · Grant/award (A): 45,200 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Iwicki Mark T — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 22,100 @ $0 · Sale (S): 5,779 @ $7.63 · Grant/award (A): 99,500 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Brazzell Romulus K — SEE REMARKS | Grant/award (A): 10,100 @ $0 · Sale (S): 2,446 @ $7.63 · Grant/award (A): 45,200 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | BAKER BROS. ADVISORS LP — 10% owner Baker Bros. Advisors (GP) LLC — 10% owner BAKER FELIX — 10% owner BAKER JULIAN — 10% owner | Purchase (P): 30,620 @ $6.44 · Purchase (P): 279,939 @ $6.44 | EDGAR |
| 2024-06-27 | 4 | Bazemore Todd — SEE REMARKS | Sale (S): 4,653 @ $4.75 | EDGAR |
| 2024-06-27 | 4 | Kharabi Darius — CHIEF BUSINESS OFFICER | Sale (S): 5,158 @ $4.75 | EDGAR |
| 2024-06-27 | 4 | Reumuth Mary — CHIEF FINANCIAL OFFICER | Sale (S): 4,163 @ $4.75 | EDGAR |
| 2024-06-27 | 4 | Iwicki Mark T — CHIEF EXECUTIVE OFFICER, Director | Sale (S): 15,168 @ $4.75 | EDGAR |
| 2024-06-27 | 4 | Brazzell Romulus K — SEE REMARKS | Sale (S): 5,489 @ $4.75 | EDGAR |
| 2024-06-12 | 4 | Farid Marjan — Director | Grant/award (A): 1,400 @ $0 · Grant/award (A): 3,150 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Myers C. Daniel — Director | Grant/award (A): 1,400 @ $0 · Grant/award (A): 3,150 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Blumenkranz Mark S. — Director | Grant/award (A): 1,400 @ $0 · Grant/award (A): 3,150 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Rosen Howard B — Director | Grant/award (A): 1,400 @ $0 · Grant/award (A): 3,150 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | KOVEN ANDREW I — Director | Grant/award (A): 1,750 @ $0 · Grant/award (A): 3,900 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | PERRY GREGORY D — Director | Grant/award (A): 1,400 @ $0 · Grant/award (A): 3,150 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Bazemore Todd — SEE REMARKS | Sale (S): 2,093 @ $6.09 | EDGAR |
| 2024-06-03 | 4 | Kharabi Darius — CHIEF BUSINESS OFFICER | Sale (S): 231 @ $6.09 | EDGAR |
| 2024-06-03 | 4 | Reumuth Mary — CHIEF FINANCIAL OFFICER | Sale (S): 1,786 @ $6.09 | EDGAR |
| 2024-06-03 | 4 | Iwicki Mark T — CHIEF EXECUTIVE OFFICER, Director | Sale (S): 7,392 @ $6.09 | EDGAR |
| 2024-06-03 | 4 | Brazzell Romulus K — SEE REMARKS | Sale (S): 2,002 @ $6.09 | EDGAR |
Recent 8-K events — KALA BIO, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-09 | 8-K | ? 8.01 — Other Events | EDGAR |
| 2026-08-28 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-07-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-02-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-23 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=KALA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →